by Sue Robbins | Oct 16, 2019 | Migraine
Although treatable, migraine often goes untreated, and even undiagnosed, as a result of multiple barriers to appropriate care. Read more here.
by Sue Robbins | Oct 14, 2019 | Migraine
On Friday, the U.S. Food and Drug Administration (FDA) approved a new medication to treat acute migraine with or without aura called Reyvow. Read more here.
by Sue Robbins | Oct 11, 2019 | Migraine
If you have migraines, one or two cups of coffee a day may be okay, but three or more could raise your risk of an attack, a new study concludes. Read more here.
by Sue Robbins | Oct 9, 2019 | Migraine
…new research out of New York University School of Medicine suggests that regularly using a smartphone-based relaxation app, called RELAXaHEAD, can help some people better manage migraine. Read more here.
by Sue Robbins | Oct 8, 2019 | Migraine
Telemedicine delivered over 1 year to patients with severe migraine-related disability was comparable to in-office visits for improving migraine disability, number of headache days, and average headache severity at 12 months, according to study results published...
by Sue Robbins | Oct 6, 2019 | Migraine
Tosymra (sumatriptan; Upsher Smith Laboratories) nasal spray is now available for the acute treatment of migraine with or without aura in adults. Read more here.
